1. Home
  2. DMRA vs UAMY Comparison

DMRA vs UAMY Comparison

Compare DMRA & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$24.60

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$8.63

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRA
UAMY
Founded
2011
1968
Country
United States
United States
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
DMRA
UAMY
Price
$24.60
$8.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$43.00
$9.44
AVG Volume (30 Days)
279.5K
13.0M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,257,708.00
Revenue This Year
N/A
$219.89
Revenue Next Year
N/A
$104.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
162.80
52 Week Low
$16.50
$1.94
52 Week High
$28.76
$19.71

Technical Indicators

Market Signals
Indicator
DMRA
UAMY
Relative Strength Index (RSI) 48.32 40.05
Support Level $22.71 $7.48
Resistance Level $28.00 $11.61
Average True Range (ATR) 1.84 1.30
MACD -0.13 -0.32
Stochastic Oscillator 52.01 3.95

Price Performance

Historical Comparison
DMRA
UAMY

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.

Share on Social Networks: